JACQUELINE LANDRY: Open Payments
NPI 1679144364 · ANDOVER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 27 payments from 8 companies in 2025. Trend: 2023 $338 · 2024 $447 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 11 | $217 |
| Astellas Pharma US Inc | 7 | $159 |
| MAYNE PHARMA COMMERCIAL LLC | 3 | $88 |
| ABBVIE INC. | 2 | $49 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $30 |
| Biogen, Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Cosette Pharmaceuticals Inc. | 1 | $21 |
Products named: SLYND, Veozah, Lynkuet, ZURZUVAE, LO LOESTRIN FE, LILETTA, GEMTESA, Vyleesi.
Industry payments across MA — which companies pay providers there.
